Funding and investment centered on own funds, with a focus on safety
First written in FY2016. 4 of 11 entries say "Restated". Latest entry: 2026-08-06.
34 other companies' latest entry also says "Restated".
- FY2025Borrowing undertaken for the employee shareholding plan and capital investmentAnnual report
「Fixed liabilities totaled ¥2,652 million, up ¥1,365 million, or 106.1%, from the end of the previous consolidated fiscal year. The main factor was a ¥1,131 million increase in long-term borrowings, due to borrowings related to the trust-based employee shareholding incentive plan (E-Ship) introduced in January this year and borrowings by a subsidiary to acquire equipment.」
While maintaining its policy of relying primarily on internally generated funds, the company incurred ¥1,131 million in long-term borrowings related to E-Ship and equipment acquisitions by a subsidiary. - FY2023RestatedAnnual report
「Both the Water Healthcare business and the medical-related business are operated, in principle, using internally generated funds earned through operating activities.」
The company has reaffirmed its policy of operating both businesses primarily with internally generated funds from operating activities. - FY2022AdvancedAnnual report
「The ¥3 billion borrowed from a bank in June the year before last, when the outlook was uncertain because of the COVID-19 pandemic, was fully repaid in June last year as the business continued to perform solidly despite the pandemic's impact.」
The ¥3 billion bank loan raised as a precaution against the COVID-19 pandemic was fully repaid in June 2021, reducing outstanding borrowings. - FY2022-Q3AdvancedAnnual report
「Liabilities totaled ¥5,645 million, down ¥1,463 million, or 20.6%, from the end of the previous consolidated fiscal year. The main factors were decreases of ¥1,003 million in long-term borrowings due within one year and ¥480 million in notes and accounts payable.」
Liabilities decreased 20.6% from the end of the previous fiscal year as borrowings and other liabilities were repaid, indicating progress in reducing debt under a finance policy centered on internally generated funds and financial security. - FY2021AdvancedAnnual report
「We raised ¥3 billion through a bank loan in June last year. However, business performance has remained solid, and we had already repaid ¥2 billion by the end of the current fiscal year. We plan to repay the remaining ¥1 billion in June this year.」
The company explained that, of the ¥3 billion borrowed as a precaution against the COVID-19 pandemic, ¥2 billion had been repaid and the remaining ¥1 billion was scheduled for repayment in June. - FY2021-Q1AdvancedAnnual report
「On the financial front, we borrowed ¥3 billion in June this year.」
The company borrowed ¥3 billion in June 2020 in preparation for upfront investments in future online sales channels, research and development, and M&A. - FY2020Added consideration of flexible external financingAnnual report
「The Water Healthcare business is operated using internally generated funds earned through operating activities, with no external financing. The medical-related business is also operated using internally generated funds, with borrowing arranged as necessary. However, in both businesses, we will consider flexible financing in light of future business development.」
The company stated that, while maintaining its policy of relying primarily on internally generated funds and emphasizing financial security, it will also consider flexible financing in preparation for future business development. - FY2017RestatedAnnual report
「In conducting its main business of manufacturing and selling electrolyzed hydrogen water ionizers, the Group covers the funds it needs primarily with internally generated funds and also raises some funds through bond issuance. The medical business is funded through bank borrowings. Temporary surplus funds are invested in highly secure financial assets, and the Group does not engage in speculative transactions.」
The Group maintains a funding policy centered on internally generated funds and an emphasis on security, while also using bank borrowings for the medical business. - FY2016First statedAnnual report
「In conducting its main business of manufacturing and selling electrolyzed hydrogen water ionizers, the Group covers the funds it needs primarily with internally generated funds and also raises some funds through bond issuance. Temporary surplus funds are invested in highly secure financial assets, and the Group does not engage in speculative transactions.」
The policy is to cover necessary funding primarily with internally generated funds and invest surplus funds in highly secure financial assets.